| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sage Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $7.79 | 31 Jul 2025 | Direct |
| UroGen Pharma Ltd. | Chief Executive Officer | Restricted Stock Units | 96,377 | 31 Jan 2025 | Direct | ||
| Allogene Therapeutics, Inc. | Director | Restricted Stock Unit | 95,400 | 18 Jun 2025 | Direct | ||
| UroGen Pharma Ltd. | Chief Executive Officer | Performance Stock Units | 87,615 | 28 Jul 2025 | Direct | ||
| Sage Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 31 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SAGE | Sage Therapeutics, Inc. | 31 Jul 2025 | 2 | $0 | 4 | Director | 31 Jul 2025, 11:48 |
| URGN | UroGen Pharma Ltd. | 28 Jul 2025 | 1 | $0 | 4 | Chief Executive Officer | 30 Jul 2025, 16:08 |
| ALLO | Allogene Therapeutics, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 23 Jun 2025, 21:03 |
| SAGE | Sage Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:13 |
| URGN | UroGen Pharma Ltd. | 31 Jan 2025 | 1 | $0 | 4 | Chief Executive Officer | 04 Feb 2025, 11:49 |
| ALLO | Allogene Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 17:34 |
| URGN | UroGen Pharma Ltd. | 31 Jan 2024 | 1 | $0 | 4 | Chief Executive Officer | 02 Feb 2024, 19:04 |
| ALLO | Allogene Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 17:03 |
| URGN | UroGen Pharma Ltd. | 31 Jan 2023 | 7 | $0 | 4 | Chief Executive Officer | 02 Feb 2023, 14:40 |
| ALLO | Allogene Therapeutics, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:57 |
| URGN | UroGen Pharma Ltd. | 31 Jan 2022 | 7 | -$62,118 | 4 | Chief Executive Officer | 02 Feb 2022, 15:32 |
| URGN | UroGen Pharma Ltd. | 03 Jan 2022 | 3 | -$429,757 | 4 | Chief Executive Officer | 07 Jan 2022, 07:38 |
| ALLO | Allogene Therapeutics, Inc. | 30 Jul 2021 | 1 | $0 | 4 | Director | 03 Aug 2021, 17:32 |
| ALLO | Allogene Therapeutics, Inc. | 30 Jul 2021 | 0 | $0 | 3 | Director | 03 Aug 2021, 17:26 |
| URGN | UroGen Pharma Ltd. | 03 Jan 2021 | 6 | -$59,968 | 4 | Chief Executive Officer | 21 May 2021, 13:44 |
| URGN | UroGen Pharma Ltd. | 03 Jun 2020 | 14 | $0 | 4/A | Chief Executive Officer | 12 Jul 2021, 18:59 |
| URGN | UroGen Pharma Ltd. | 03 Feb 2020 | 8 | $0 | 4/A | Chief Executive Officer | 12 Jul 2021, 18:57 |